Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSGU) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for BrightSpring Health Services (BTSGU) over the last 3 years, with Q3 2025 value amounting to -$23.8 million.

  • BrightSpring Health Services' Cash from Investing Activities rose 3367.85% to -$23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.0 million, marking a year-over-year increase of 3852.44%. This contributed to the annual value of -$140.2 million for FY2024, which is 431.74% down from last year.
  • Per BrightSpring Health Services' latest filing, its Cash from Investing Activities stood at -$23.8 million for Q3 2025, which was up 3367.85% from -$23.2 million recorded in Q2 2025.
  • BrightSpring Health Services' Cash from Investing Activities' 5-year high stood at -$15.8 million during Q4 2024, with a 5-year trough of -$57.7 million in Q2 2024.
  • In the last 3 years, BrightSpring Health Services' Cash from Investing Activities had a median value of -$24.2 million in 2025 and averaged -$31.4 million.
  • Per our database at Business Quant, BrightSpring Health Services' Cash from Investing Activities tumbled by 7716.31% in 2024 and then soared by 5971.19% in 2025.
  • BrightSpring Health Services' Cash from Investing Activities (Quarter) stood at -$17.0 million in 2023, then rose by 7.3% to -$15.8 million in 2024, then crashed by 50.58% to -$23.8 million in 2025.
  • Its Cash from Investing Activities stands at -$23.8 million for Q3 2025, versus -$23.2 million for Q2 2025 and -$24.2 million for Q1 2025.